Literature DB >> 26327190

Are capillary DBS applicable for therapeutic drug monitoring of common antipsychotics? A proof of concept.

Lisbeth Patteet1,2, Kristof E Maudens1, Christophe P Stove3, Willy E Lambert3, Manuel Morrens4,5, Bernard Sabbe4,6, Hugo Neels1,2.   

Abstract

AIM: DBS sampling has been proposed as an alternative for venous blood collection in therapeutic drug monitoring (TDM) of antipsychotics. For implementation in routine practice, a comparison between capillary and venous blood concentrations is mandatory.
RESULTS: A DBS method for quantification of antipsychotics was clinically validated. First, whole blood therapeutic ranges were calculated using the blood:serum ratio. Calculation of DBS:blood ratios and Passing-Bablok regression analysis demonstrated that concentrations obtained by DBS analysis were highly comparable to those obtained by conventional whole blood analysis. Clinical interpretation of serum, whole blood and DBS concentrations were highly identical (sensitivity 91.6-97.6%).
CONCLUSION: This is the first clinical study demonstrating the value of DBS sampling in TDM of antipsychotics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26327190     DOI: 10.4155/bio.15.100

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  4 in total

1.  Determination of Antidepressants and Antipsychotics in Dried Blood Spots (DBSs) Collected from Post-Mortem Samples and Evaluation of the Stability over a Three-Month Period.

Authors:  Matteo Moretti; Francesca Freni; Beatrice Valentini; Claudia Vignali; Angelo Groppi; Silvia Damiana Visonà; Antonio Marco Maria Osculati; Luca Morini
Journal:  Molecules       Date:  2019-10-09       Impact factor: 4.411

2.  Development, validation, and application of a quantitative volumetric absorptive microsampling-based method in finger prick blood by means of LC-HRMS/MS applicable for adherence monitoring of antipsychotics.

Authors:  Cathy M Jacobs; Lea Wagmann; Markus R Meyer
Journal:  Anal Bioanal Chem       Date:  2021-01-30       Impact factor: 4.142

3.  Comparison of Capillary and Venous Plasma Drug Concentrations After Repeated Administration of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole.

Authors:  Bart Remmerie; Marc De Meulder; Jay Ariyawansa; Adam Savitz
Journal:  Clin Pharmacol Drug Dev       Date:  2016-08-17

4.  Comparison of Capillary and Venous Drug Concentrations After Administration of a Single Dose of Risperidone, Paliperidone, Quetiapine, Olanzapine, or Aripiprazole.

Authors:  Bart Remmerie; Marc De Meulder; Sveta Weiner; Adam Savitz
Journal:  Clin Pharmacol Drug Dev       Date:  2016-09-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.